TAKOMA PARK, Md.--(BUSINESS WIRE)--The Jerome Canady Research Institute for Advanced and Biological Technological Sciences (JCRI-ABTS) and US Medical Innovations, LLC (USMI) are pleased to announce today a ground-breaking achievement in surgical and robotic technology. The Canady Robotic AI Surgical System is the world’s first AI robotic system that delivers cold atmospheric plasma (CAP) which is a three-dimensional non-contact bioelectric pulse electromagnetic field.

TAKOMA PARK，医学博士-（商业线）-Jerome Canady先进和生物技术科学研究所（JCRI-ABTS）和美国医学创新有限责任公司（USMI）很高兴今天宣布在外科手术方面取得突破性成就和机器人技术。Canady机器人AI手术系统是世界上第一个提供冷大气等离子体（CAP）的AI机器人系统，CAP是一种三维非接触式生物电脉冲电磁场​​。

CAP selectively targets and kills microscopic tumor cells during surgery without damaging non-cancerous surrounding tissue. Despite advancements in surgery, chemotherapy, radiation, immunotherapy and biologic targeted therapy regimes, microscopic residual disease (5% to 65%) can still persist which contributes to local regional recurrence and poor survival.

CAP在手术期间选择性地靶向并杀死微观肿瘤细胞而不损伤非癌性周围组织。尽管在手术，化疗，放疗，免疫治疗和生物靶向治疗方案方面取得了进展，但微小残留病（5%至65%）仍然可以持续存在，这导致局部区域复发和生存率低。

The Canady Robotic AI Surgical System will be displayed at the First Global Surgical Oncology Summit in Jerusalem, Israel (January 30 to February 2, 2024)..

Canady机器人AI手术系统将在以色列耶路撒冷的第一届全球肿瘤外科峰会（2024年1月30日至2月2日）上展示。。

The Canady Robotic AI Surgical System’s key components are a Motorized Positioning Arm, Speech Recognition Canady Electrosurgical Generator known as ORLI™, Controller for CAP Devices, Robotic Assisted End Effectors which can be used in Open, Laparoscopic, Thoracoscopic, Endoscopic and Mini-invasive surgical procedures.

Canady机器人AI手术系统的关键部件是电动定位臂，语音识别Canady电外科发生器，称为ORLI™, 用于CAP装置的控制器，可用于开放式，腹腔镜，胸腔镜，内窥镜和微创外科手术的机器人辅助末端效应器。

The System also provides the surgeon with 10 degrees of freedom, Speech activation of the Robotic movements, AI Powered Software Programs, 3D Navigational Guided Surgical Planning, Advance Contour Tracking of the CAP Beam, Pre-Programmed CAP Dosimetry data for selectively targeting 32 Cancer cell types and a compact mobile design..

该系统还为外科医生提供10个自由度，机器人运动的语音激活，AI驱动的软件程序，3D导航引导的手术计划，帽束的预先轮廓跟踪，用于选择性靶向的预编程帽剂量测量数据32癌细胞类型和紧凑的移动设计。。

JCRI-ABTS has been granted 5 key U.S. Patents: Application of delivering CAP technology to selectively target cancer cells at the surgical margin, Integrated Cold Plasma and High Frequency Electrosurgical System and Method for the Use and Treatment Therapy, Cold Plasma Robotic Delivery System by incorporating AI-enabled Speech Recognition, Pre-programed Dosimetry Data and Protocols for combined care such as chemotherapy, radiation, and surgery.

JCRI-ABTS已获得5项美国重要专利：应用CAP技术在手术边缘选择性靶向癌细胞，集成冷等离子体和高频电外科系统以及使用和治疗方法，通过结合AI启用的语音识别的冷等离子体机器人传输系统，预先编程的剂量测定数据和联合护理方案，如化疗，放疗和手术。

These achievements signify a significant leap forward in the integration of robotics and artificial intelligence during surgical procedures..

这些成就标志着外科手术中机器人与人工智能集成的重大飞跃。。

Taisen Zhuang, PhD, Chief Technology Officer stated, “The Canady Robotic AI Surgical System sets a new precedent for Robotic Cancer Surgery by combining AI Technology and CAP. This innovation sets a higher standard by enhancing accuracy, precision, and safety in the OR.”

首席技术官Taisen Zhuang博士说：“Canady机器人AI手术系统通过结合AI技术和CAP为机器人癌症手术开创了新的先例。这项创新通过提高手术室的准确性，精确性和安全性来设定更高的标准。”

Saravana Murthy, PhD, Vice President of Research added, “This smart integrated “System” represents the world’s first therapy designed to selectively eliminate microscopic tumor cells at the surgical margins.”

研究副总裁Saravana Murthy博士补充说：“这种智能集成”系统代表了世界上第一种旨在选择性消除手术边缘微小肿瘤细胞的疗法。”

Jerome Canady, MD, FACS, CEO and Surgical Oncologist stated, “This technology will transform the landscape of the OR. ORLI™ is a user-friendly system controlling the entire integrated SMART Operating Room. The platform will serve as a SIRI, ALEXA, and GOOGLE HOME for the operating room. Data collected from our recent FDA Phase 1 Clinical Trial on Stage 4 Cancer Patients combined with ten years of in-vitro translational molecular research data have been imported into the Canady Robotic AI Surgical System.

医学博士Jerome Canady，FACS，首席执行官和外科肿瘤学家说：“这项技术将改变OR.ORLI的格局™ 是一个用户友好的系统，控制整个集成的智能手术室。该平台将作为手术室的SIRI，ALEXA和GOOGLE主页。从我们最近对4期癌症患者进行的FDA 1期临床试验中收集的数据与十年的体外翻译分子研究数据相结合，已导入Canady机器人AI手术系统。

This achievement signifies a significant leap forward integrating artificial intelligence and robotics in surgery. I would like to express my gratitude to our Engineers and Scientist for their role in achieving this revolutionary milestone.”.

这一成就标志着将人工智能和机器人技术整合到外科手术中的重大飞跃。我想感谢我们的工程师和科学家在实现这一革命性里程碑方面所发挥的作用。”。

About JCRI-ABTS

关于JCRI-ABTS

JCRI-ABTS is a state-of-the-art BSL 2 Translational Molecular Research Institute focusing on Plasma Oncotherapeutics (a new cancer treatment modality) using Cold Atmospheric Plasma to investigate and selectively treat cancer without damaging normal tissue.

JCRI-ABTS是一个最先进的BSL 2转化分子研究所，专注于血浆肿瘤治疗（一种新的癌症治疗方式），使用冷大气血浆研究和选择性治疗癌症而不损害正常组织。

About US Medical Innovations

关于我们的医疗创新

US Medical Innovations, LLC (USMI), based out of Takoma Park, MD, is a privately held FDA registered life science, biomedical and robotic device company. USMI is dedicated to expanding the boundaries of plasma medicine by pioneering new technologies for the development of state-of-the-art medical devices that advance patient outcomes and improve human lives..

美国医疗创新有限责任公司（USMI）位于Takoma Park，MD，是一家私营的FDA注册生命科学，生物医学和机器人设备公司。USMI致力于通过开创新技术扩展血浆医学的界限，开发可促进患者预后和改善人类生活的最先进医疗设备。。